篇序 |
作者 |
論文題目 | 發表雜誌名稱 (含年月/卷期/頁次) |
屬性 (SCI、SSCI、IEEE) |
---|---|---|---|---|
1 | 杜漢祥(3) | Association of adherence to antiretroviral therapy with economic burden of cardiovascular disease in HIV-infected population. | Eur J Prev Cardiol. 2020 Mar 2:2047487320908085. | SCI |
2 | 杜漢祥(2) | Early scale-up of antiretroviral therapy at diagnosis for reducing economic burden of cardiometabolic disease in HIV-infected population. | AIDS. 2020 May 1;34(6):903-911. | SCI |
3 |
杜漢祥(1) |
Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy. | Int J Infect Dis. 2020 Feb;91:44-49. | SCI |
4 | 杜漢祥(4) | Taiwan guideline on oral pre-exposure prophylaxis for HIV prevention - 2018 update. | J Microbiol Immunol Infect. 2020 Feb;53(1):1-10. | SCI |
5 | 湯宏仁(9) | Be Careful with Adverse Events Caused by Cefoperazone-Sulbactam | Antimicrob Agents Chemother 2020 Jan 27;64(2):e02028-19. | SCI |
6 | 湯宏仁(1) | Carbapenem/β-lactamase inhibitor combination in complicated urinary tract infection. | J Infect 2020 Jan;80(1):121-142. | SCI |
7 | 湯宏仁(1) | Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia | Lancet Infect Dis 2020 Jan;20(1):20 | SCI |
8 | 湯宏仁(C) | Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis | Medicine (Baltimore) 2020 Feb;99(8):e19321. | SCI |
9 | 湯宏仁(C) | Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae | J Microbiol Immunol Infect 2020 Feb 15;S1684-1182. | SCI |
10 |
蘇柏安(4) |
In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products. | Antibiotics (Basel) 2020 Feb 12;9(2):77 | SCI |
11 | 湯宏仁(C) | The use of ceftolozane-tazobactam in the treatment of complicated intra-abdominal infections and complicated urinary tract infections-A meta-analysis of randomized controlled trials | Int J Antimicrob Agents 2020 Feb;55(2):105858. | SCI |
12 | 湯宏仁(8) | The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane | PLoS One 2020 Feb 12;15(2):e0228874 | SCI |
13 | 蘇柏安(1) 湯宏仁(3) |
In Vitro Synergy of Pongamia pinnata Extract in Combination with Antibiotics for Inhibiting and Killing Methicillin-Resistant Staphylococcus aureus. | Antibiotics (Basel) . 2020 Feb 29;9(3):103 | SCI |
14 | 湯宏仁(7) | Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy. | Int J Infect Dis . 2020 Feb;91:44-49. | SCI |
15 | 湯宏仁(4) | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. | Int J Antimicrob Agents . 2020 Mar;55(3):105924. | SCI |
16 | 湯宏仁(1) | The Safety of Eravacycline in the Treatment of Acute Bacterial Infection | Clin Infect Dis 2020 Jun 10;70(12):2750-2751. | SCI |
17 | 湯宏仁(1) | Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia. | Medicine (Baltimore) 2020 Jul 17;99(29):e21223. | SCI |
18 | 湯宏仁(1) | Plazomicin-associated Nephrotoxicity | Clin Infect Dis 2020 Aug 14;71(4):1130-1131. | SCI |
19 | 湯宏仁(1) | The clinical efficacy of lefamulin in the treatment of elderly patients with community-acquired bacterial pneumonia | J Thorac Dis . 2020 Aug;12(8):4588-4590. | SCI |
20 | 湯宏仁(3) | Collateral benefits on other respiratory infections during fighting COVID-19. | Med Clin (Engl Ed). 2020 Sep 25;155(6):249-253. | SCI |
21 | 湯宏仁(1) | Lefamulin for treating community-acquired bacterial pneumonia in adult patients aged < 65 years. | Clin Infect Dis. 2020 Sep 12;71(6):1582. | SCI |
22 | 湯宏仁(19) | National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) | Antimicrob Agents Chemother. 2020 Sep 21;64(10) | SCI |
23 | 湯宏仁(14) | Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV | J Antimicrob Chemother 2020 Oct 1;75(10):2986-2993. | SCI |
24 | 湯宏仁(1) | Clinical efficacy and safety of novel carbapenem/β-lactamase inhibitor combinations against carbapenem-non-susceptible Gram-negative bacterial infection. | J Glob Antimicrob Resist 2020 Dec;23:111-112. | SCI |
25 |
陳宏睿(1) |
Warning signs and severe dengue in end stage renal disease dialysis patients. | J Microbiol Immunol Infect. 2020 Dec;53(6):979-985. | SCI |
26 | 湯宏仁(C) | Impact of COVID-19 preventative measures on dengue infections in Taiwan. | J Med Virol 2020 Nov 3. doi: 10.1002/jmv.26650. | SCI |
27 | 湯宏仁(3) | UvrY is required for the full virulence of Aeromonas dhakensis | Virulence 2020 Dec;11(1):502-520. | SCI |
28 | 陳宏睿(1) 湯宏仁(4) 蘇柏安(5) |
The implementation of an active surveillance integrating information technology and drive-through coronavirus testing station for suspected COVID-19 cases. | J Infect. 2020 Sep 3 : 4831. | SCI |
29 | 陳宏睿(1) 湯宏仁(C) |
傳染性氣溶膠 (aerosols) 的顆粒大小對感染控制的意義 | 感染控制雜;2020;30:319-325 | |
30 | 陳宏睿(1) 湯宏仁(2) |
新冠肺炎之實際照護經驗 | 內科學誌 2020:31:262-265 | |
21 | 李健明(3) | Symmetric Cryptography With Shift 2 n-1 , Hash Transformation, Optimization-Based Controller for Medical Image Infosecurity: Case Study in Mammographic Image | IEEE Photonics Journal, Vol. 12, No. 3, 2020, pp. 1-16 | SCI/SCIE |
22 | 李健明(3) | Medical Image Infosecurity Using Hash Transformation and Optimization-Based Controller in a Health Information System: Case Study in Breast Elastography and X-Ray Image | IEEE Access, Vol. 8, 2020, pp. 61340-61354 | SCI/SCIE |